Office of the Commissioner of Lobbying of CanadaOffice of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Monthly Communication Reports in: January 2016

Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.

The list below is sorted by communication date, beginning with the most recent.

Innovative Medicines Canada/Médicaments novateurs Canada

RUSSELL WILLIAMS, PRESIDENT (Organization)

Results 1-9 of 9

  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • TJ Harvey, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-01-28
    Posted date: 2016-02-15
    Communication number: 371-368514 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ginette Petitpas Taylor, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-01-27
    Posted date: 2016-02-15
    Communication number: 371-368516 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rodger Cuzner, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-01-27
    Posted date: 2016-02-15
    Communication number: 371-368507 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rob Rosenfeld, Chief of Staff | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-01-26
    Posted date: 2016-02-15
    Communication number: 371-368504 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Anil Arora, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-01-25
    Posted date: 2016-02-15
    Communication number: 371-368445 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sean Fraser, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-01-21
    Posted date: 2016-02-15
    Communication number: 371-368511 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Robert Asselin, Director of Policy | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-01-21
    Posted date: 2016-02-15
    Communication number: 371-368509 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Greg Fergus, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-01-21
    Posted date: 2016-02-15
    Communication number: 371-368502 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tyler Meredith, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
    Communication date: 2016-01-18
    Posted date: 2016-02-15
    Communication number: 371-368517 View monthly communication report

Return to Monthly Communication Reports by Reporting Period

Date Modified: